
  
    
      
        
        Randomized_NNP trials_NNS and_CC observational_NN studies_NNS have_VBP conclusively_RB shown_VBN a_DT marked_VBN improvement_NN
        in_IN several_JJ cardiovascular_JJ risk_NN factors_NNS when_WRB obese_NN individuals_NNS lose_VBP weight_NN ,_, including_VBG
        decreases_NNS in_IN blood_NN pressure_NN ,_, and_CC improvements_NNS in_IN the_DT lipid_NN profile_NN and_CC glucose_NN metabolism_NN ._.
        These_DT results_NNS are_VBP closely_RB consistent_JJ with_IN observational_NN data_NNS linking_VBG weight_NN gain_NN to_TO
        worsening_NN of_IN these_DT cardiovascular_JJ risk_NN factors_NNS ,_, and_CC to_TO their_PRP$ natural_JJ sequelae_NN ,_, clinical_JJ
        cardiovascular_JJ events_NNS ._. Obesity_NNP is_VBZ also_RB strongly_RB associated_VBN with_IN increased_VBN risk_NN of_IN cancer_NN at_IN
        various_JJ sites_NNS ._. With_IN such_JJ compelling_JJ evidence_NN of_IN the_DT adverse_JJ effects_NNS of_IN obesity_NN and_CC
        overweight_NN [_NN 1_CD –_NN 4_CD ]_NN ,_, why_WRB has_VBZ there_EX been_VBN a_DT continuing_VBG controversy_NN about_IN its_PRP$ association_NN with_IN
        overall_JJ mortality_NN ?_.
        In_IN their_PRP$ paper_NN in_IN this_DT month_NN 's_POS 
        PLoS_NNP Medicine_NNP ,_, Jaakio_NNP Kaprio_NNP and_CC colleagues_NNS conclude_VBP that_IN “ deliberate_JJ
        weight_NN loss_NN in_IN overweight_NN subjects_NNS without_IN known_VBN co-morbidities_JJ may_MD be_VB hazardous_JJ in_IN the_DT
        long_JJ term_NN” [_NN 5_CD ]_NN ._. Do_VBP the_DT data_NNS really_RB support_VBP such_JJ a_DT conclusion_NN ?_. An_DT examination_NN of_IN this_DT paper_NN
        illustrates_VBZ several_JJ of_IN the_DT complexities_NNS in_IN approaching_VBG this_DT seemingly_RB simple_JJ question_NN ._.
      
      
        Evidence_NN from_IN Epidemiological_NNP Studies_NNPS
        Epidemiologic_NNP studies_NNS of_IN the_DT relation_NN between_IN overweight_NN and_CC mortality_NN typically_RB must_MD
        address_VB three_CD principal_JJ concerns_NNS [_NN 6_CD ]_NN ._. First_LS ,_, in_IN many_JJ populations_NNS ,_, cigarette_NN smokers_NNS tend_VBP to_TO
        be_VB leaner_JJR than_IN nonsmokers_NNS ._. Because_IN cigarette_NN smoking_NN is_VBZ such_JJ a_DT strong_JJ risk_NN factor_NN for_IN
        mortality_NN ,_, failure_NN to_TO adjust_VB for_IN this_DT adequately_RB can_MD lead_VB to_TO confounding_VBG ,_, with_IN the_DT
        erroneous_JJ conclusion_NN that_IN leanness_NNS carries_VBZ increased_VBN risk_NN of_IN death_NN ._. Statistical_NNP adjustment_NN
        for_IN smoking_NN is_VBZ often_RB insufficient_JJ to_TO account_VB for_IN this_DT difficulty_NN ._. Smoking_NN can_MD lead_VB to_TO
        medical_JJ conditions_NNS ,_, sometimes_RB sub-clinical_JJ ,_, that_WDT are_VBP associated_VBN with_IN decreased_VBD body_NN weight_NN ,_,
        such_JJ as_IN chronic_JJ obstructive_JJ pulmonary_JJ disease_NN ._. The_DT presence_NN of_IN symptoms_NNS or_CC diagnosed_VBN
        conditions_NNS may_MD induce_VB smokers_NNS to_TO quit_VB ._. Moreover_RB ,_, the_DT intensity_NN of_IN smoking_NN is_VBZ related_VBN to_TO
        both_DT risk_NN of_IN death_NN and_CC body_NN mass_NN index_NN ._. For_IN these_DT reasons_NNS ,_, the_DT best_JJS way_NN to_TO assess_VB the_DT
        impact_NN of_IN overweight_NN on_IN risk_NN of_IN mortality_NN is_VBZ simply_RB to_TO exclude_VB current_JJ and_CC past_JJ smokers_NNS ._.
        Kaprio_NNP and_CC colleagues_NNS '_POS study_NN differentiated_JJ only_RB current_JJ smoker_NN or_CC nonsmoker_NN ._. Thus_RB ,_,
        never-smokers_JJ were_VBD included_VBN in_IN the_DT same_JJ category_NN as_IN past_JJ smokers_NNS ,_, regardless_RB of_IN how_WRB much_RB
        the_DT past_JJ smokers_NNS had_VBD smoked_VBD or_CC their_PRP$ reasons_NNS for_IN quitting_VBG ._.
        A_DT second_JJ difficulty_NN in_IN some_DT epidemiologic_JJ studies_NNS is_VBZ the_DT inclusion_NN of_IN intermediary_JJ
        factors_NNS as_IN co-variates_JJ ._. Weight_NNP loss_NN improves_VBZ hypertension_NN and_CC diabetes_NN ,_, so_RB including_VBG these_DT
        as_IN co-variates_JJ would_MD tend_VB to_TO attenuate_NN the_DT apparent_JJ benefit_NN of_IN weight_NN loss_NN ._. In_IN the_DT present_JJ
        study_NN ,_, the_DT authors_NNS appropriately_RB excluded_VBN people_NNS with_IN diabetes_NN ,_, and_CC adjustment_NN for_IN
        hypertension_NN appeared_VBD to_TO have_VB little_JJ impact_NN ._.
        The_DT third_JJ and_CC most_RBS difficult_JJ issue_NN in_IN studies_NNS of_IN overweight_NN and_CC mortality_NN is_VBZ reverse_JJ
        causation_NN ,_, the_DT impact_NN of_IN disease_NN on_IN body_NN weight_NN ._. This_DT can_MD occur_VB either_CC through_IN the_DT
        biological_JJ impact_NN of_IN a_DT condition_NN (_( diagnosed_VBN or_CC preclinical_JJ )_) or_CC as_IN an_DT inducement_NN to_TO attempt_VB
        to_TO lose_VB weight_NN as_IN a_DT means_NN to_TO improve_VB health_NN ._. The_DT authors_NNS '_POS keen_JJ recognition_NN of_IN this_DT problem_NN
        provides_VBZ a_DT significant_JJ strength_NN to_TO the_DT present_JJ study_NN ._. The_DT authors_NNS appropriately_RB excluded_VBN
        individuals_NNS with_IN a_DT wide_JJ range_NN of_IN conditions_NNS to_TO identify_VB an_DT apparently_RB healthy_JJ cohort_NN ._. This_DT
        critical_JJ step_NN is_VBZ often_RB ignored_VBN ._. Sometimes_RB ,_, investigators_NNS also_RB exclude_VBP deaths_NNS that_WDT occur_VBP in_IN
        the_DT first_JJ few_JJ years_NNS after_IN follow-up_JJ ,_, to_TO reduce_VB the_DT impact_NN of_IN reverse_NN causation_NN ._. Such_JJ lagged_VBN
        analyses_NNS can_MD be_VB helpful_JJ ,_, but_CC some_DT chronic_JJ conditions_NNS of_IN long_JJ duration_NN ,_, such_JJ as_IN depression_NN ,_,
        chronic_JJ lung_NN disease_NN ,_, and_CC heart_NN failure_NN (_( conditions_NNS that_WDT often_RB may_MD not_RB reach_VB the_DT level_NN of_IN
        clinical_JJ diagnosis_NN )_) can_MD lead_VB to_TO lower_JJR body_NN weight_NN and_CC higher_JJR mortality_NN risk_NN ._. Hence_RB ,_, that_DT
        strategy_NN (_( not_RB employed_VBN by_IN Kaprio_NNP and_CC colleagues_NNS )_) may_MD not_RB fully_RB avoid_VB the_DT problem_NN ._.
      
      
        The_DT Difficulties_NNP of_IN Assessing_NNP the_DT Effects_NNPS of_IN Intention_NNP to_TO Lose_NNP Weight_NNP
        As_IN a_DT further_JJ step_NN toward_IN reducing_VBG the_DT potential_JJ bias_NN of_IN the_DT impact_NN of_IN disease_NN on_IN body_NN
        weight_NN ,_, the_DT authors_NNS identified_VBD individuals_NNS with_IN intent_NN to_TO lose_VB weight_NN ._. Unintended_NNP weight_NN
        loss_NN is_VBZ well_RB known_VBN as_IN an_DT ominous_JJ clinical_JJ sign_NN ,_, usually_RB signifying_VBG a_DT serious_JJ illness_NN ._. Just_RB
        over_IN a_DT third_JJ of_IN the_DT overweight_NN subjects_NNS in_IN the_DT Kaprio_NNP cohort_NN had_VBD expressed_VBN intent_NN to_TO lose_VB
        weight_NN at_IN baseline_NN in_IN 1975_CD ._. It_PRP is_VBZ interesting_JJ to_TO note_VB that_IN despite_IN this_DT intention_NN ,_, as_IN a_DT
        group_NN ,_, the_DT median_JJ weight_NN change_NN in_IN the_DT ensuing_VBG six_CD years_NNS was_VBD a_DT gain_NN of_IN 0_CD ._. 33_CD kg_NN /_NN m_NN
        2_CD ,_, almost_RB identical_JJ to_TO the_DT weight_NN change_NN in_IN the_DT group_NN that_WDT had_VBD not_RB
        expressed_VBN intent_NN to_TO lose_VB weight_NN (_( gain_NN of_IN 0_CD ._. 31_CD kg_NN /_NN m_NN
        2_LS )_) ._. Thus_RB ,_, this_DT study_NN cannot_NN fairly_RB be_VB characterized_VBN as_IN an_DT assessment_NN of_IN
        intentional_JJ weight_NN loss_NN and_CC its_PRP$ subsequent_JJ effect_NN on_IN mortality_NN ._. Because_IN the_DT changes_NNS in_IN
        weight_NN are_VBP so_RB similar_JJ in_IN these_DT two_CD groups_NNS ,_, it_PRP is_VBZ implausible_JJ to_TO attribute_VB the_DT weight_NN loss_NN
        in_IN the_DT intent-to-lose_JJ group_NN to_TO that_DT intention_NN ._. These_DT findings_NNS render_VB the_DT results_NNS
        particularly_RB difficult_JJ to_TO interpret_VB ._.
        Other_JJ important_JJ limitations_NNS include_VBP the_DT very_RB small_JJ number_NN of_IN endpoints—only_RB 268_CD total_JJ
        deaths_NNS in_IN the_DT cohort_NN ._. When_WRB further_JJ subdivided_JJ according_VBG to_TO intention_NN to_TO lose_VB weight_NN ,_, and_CC
        categories_NNS of_IN weight_NN change_NN ,_, the_DT numbers_NNS are_VBP far_RB from_IN sufficient_JJ for_IN reliable_JJ estimates_NNS ._.
        For_IN example_NN ,_, the_DT main_JJ conclusions_NNS are_VBP based_VBN on_IN the_DT subgroup_NN of_IN those_DT with_IN intent_NN to_TO lose_VB
        weight_NN who_WP actually_RB lost_VBD weight_NN ;_: this_DT group_NN had_VBD only_RB 42_CD deaths_NNS ,_, of_IN which_WDT ten_CD were_VBD violent_JJ ._.
        Another_DT related_VBN difficulty_NN is_VBZ that_IN this_DT cohort_NN ,_, though_IN overweight_NN ,_, is_VBZ not_RB drastically_RB
        obese_NN ._. The_DT median_JJ body_NN mass_NN index_NN (_( BMI_NNP )_) was_VBD 26_CD ._. 7_CD kg_NN /_NN m_NN
        2_CD ,_, and_CC fewer_JJR than_IN 10_CD %_NN of_IN people_NNS had_VBD a_DT BMI_NNP greater_JJR than_IN 30_CD ._. With_IN such_JJ a_DT
        narrow_JJ range_NN of_IN BMI_NNP ,_, coupled_VBN with_IN the_DT very_RB small_JJ changes_NNS in_IN weight_NN during_IN the_DT six_CD years_NNS of_IN
        initial_JJ follow-up_JJ ,_, even_RB a_DT very_RB large_JJ study_NN would_MD not_RB have_VB sufficient_JJ power_NN to_TO detect_VB
        plausible_JJ relative_JJ risks_NNS associated_VBN with_IN weight_NN change_NN ._.
      
      
        What_WP Advice_NNP Should_NNP Be_VB Given_VBN ?_.
        Given_VBN the_DT well-known_JJ adverse_JJ metabolic_JJ consequences_NNS of_IN overweight_NN and_CC obesity_NN ,_, the_DT
        strong_JJ links_NNS with_IN cardiovascular_JJ disease_NN and_CC several_JJ other_JJ serious_JJ illnesses_NNS ,_, and_CC the_DT
        absence_NN of_IN any_DT plausible_JJ adverse_JJ biologic_JJ consequences_NNS of_IN maintaining_VBG normal_JJ weight_NN (_( BMI_NNP 19_CD
        to_TO 25_CD )_) ,_, it_PRP seems_VBZ prudent_JJ to_TO continue_VB advising_VBG adults_NNS to_TO seek_VB to_TO maintain_VB a_DT weight_NN within_IN
        that_DT range_NN ._. The_DT results_NNS from_IN Kaprio_NNP et_CC al_NN ,_, although_IN they_PRP raise_VBP questions_NNS about_IN the_DT effects_NNS
        of_IN weight_NN loss_NN ,_, do_VBP not_RB cast_VB serious_JJ doubt_NN on_IN that_DT advice_NN ._.
      
    
  
